Cargando…

Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival

Antibody-mediated rejection (AMR) is an important cause of graft loss after organ transplantation. It is caused by anti-donor-specific antibodies especially anti-HLA antibodies. C4d had been regarded as a diagnosis marker for AMR. Although most early AMR episodes can be successfully controlled or re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qiquan, Yang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816029/ https://www.ncbi.nlm.nih.gov/pubmed/24222777 http://dx.doi.org/10.1155/2013/859761

Ejemplares similares

Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection
por: Einecke, Gunilla, et al.
Publicado: (2018)

Capillary Dilation and Rarefaction Are Correlated with Intracapillary Inflammation in Antibody-Mediated Rejection
por: Li, Xue, et al.
Publicado: (2014)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

The impact of early and late acute rejection on graft survival in renal transplantation
por: Koo, Eun Hee, et al.
Publicado: (2015)

Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a Mitochondria-mediated metabolic disorder
por: Zhang, Yannan, et al.
Publicado: (2023)

The Diagnostic Value of Transcription Factors T-bet/GATA3 Ratio in Predicting Antibody-Mediated Rejection
por: Li, Xue, et al.
Publicado: (2013)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection
por: Borski, Anita, et al.
Publicado: (2022)

Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021)

Late Cardiac Antibody-Mediated Rejection: A Only Heart Duel
por: Costa, Catarina, et al.
Publicado: (2022)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection
Publicado: (1981)

Noninvasive and quantitative measurement of C4d deposition for the diagnosis of antibody-mediated cardiac allograft rejection
por: Liao, Tao, et al.
Publicado: (2018)

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017)

Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model
por: Ma, Maolin, et al.
Publicado: (2021)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
por: Zhao, Daqiang, et al.
Publicado: (2018)

B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome
por: Xu, Haiyan, et al.
Publicado: (2018)

Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection
por: Vij, Mukul, et al.
Publicado: (2022)

Corrigendum: Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model
por: Ma, Maolin, et al.
Publicado: (2021)

Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience
por: Surendra, M., et al.
Publicado: (2016)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
por: Nourié, Nicole, et al.
Publicado: (2022)

Comparative Analysis of Determinants and Outcome of Early and Late Acute Antibody Mediated Rejection (ABMR)
por: Karthikeyan, Balasubramanian, et al.
Publicado: (2023)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
por: Sablik, Kasia A., et al.
Publicado: (2020)

Expression of MMP-2 and TIMP-1 in Renal Tissue of Patients with Chronic Active Antibody-mediated Renal Graft Rejection
por: Yan, Qiang, et al.
Publicado: (2012)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival
por: Yang, Zhe, et al.
Publicado: (2021)

Notch3 expression in capillary pericytes predicts worse graft outcome in human renal grafts with antibody‐mediated rejection
por: Xu‐Dubois, Yichun, et al.
Publicado: (2022)

IMMUNOSUPPRESSIVE AND GRAFT-REJECTING ANTIBODIES IN HETEROLOGOUS ANTI-LYMPHOCYTIC SERUM
por: Cinader, B., et al.
Publicado: (1971)

A severe Mycoplasma pneumoniae pneumonia inducing an acute antibody-mediated pulmonary graft rejection
por: Démir, Sarah, et al.
Publicado: (2017)

Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants
por: Nakamura, Tsukasa, et al.
Publicado: (2021)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022)

The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection
por: Uebayashi, Elena Yukie, et al.
Publicado: (2022)

Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation
por: Schotters, Felicitas Leonie, et al.
Publicado: (2021)

Long-term CMV monitoring and chronic rejection in renal transplant recipients
por: Ishikawa, Shoko, et al.
Publicado: (2023)

Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
por: de Weerd, Annelies, et al.
Publicado: (2014)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Chronic active antibody mediated rejection associated with human leukocyte antigen-C*07 antibodies
por: Dorwal, P., et al.
Publicado: (2016)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q2htjlcs7op6m96kpm6topbhdq